CNN on MSN15d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...
KOAT Albuquerque16d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and ... to manage blood pressure, including ACE inhibitors ...
abc7NY15d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...
Healio22d
Obesity medications can tackle metabolic cardiorenal disease
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease ... proximal sodium transport, intraglomerular pressure and albuminuria. This improves energy ...
NBC Washington16d
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes ... by paying attention to blood pressure. The rate of serious adverse ...